Tag: OCGN

  • Ocugen Could Easily Soar to Higher Highs

    Ocugen Could Easily Soar to Higher Highs

    Ocugen has been explosive. Since December 2020, the stock ran from a low of 29 cents to $13 good for a return of 4,383%.  However, even after the run, OCGN could see further upside. All after its development partner, Bharat Biotech, announced the results of the first interim analysis of its Phase 3 study of…